Pacira Pharmaceuticals buy Barclays PLC
Start price
08.05.24
/
50%
€26.80
Target price
08.05.25
€35.35
Performance (%)
-25.75%
End price
09.05.25
€19.90
Summary
This prediction ended on 09.05.25 with a price of €19.90. The prediction for Pacira Pharmaceuticals disappointed with a performance of -25.75%. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 8.911% | 8.911% | 18.919% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Barclays_PLC for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Barclays PLC from $40.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
23.10.23
23.10.23
€53.51
23.10.24
23.10.24
-38.93%
24.10.24
24.10.24
